Private equity firm Everstone Capital has signed an agreement to acquire a controlling stake in Calibre, a specialty ingredients manufacturer focused on the pharmaceutical, nutritional and personal care segments, the investor said in a statement on Sunday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
